Literature DB >> 9212866

Engineering of functional chimeric protein G-Vargula luciferase.

Y Maeda1, H Ueda, J Kazami, G Kawano, E Suzuki, T Nagamune.   

Abstract

Luciferase of Vargula hilgendorfli is infinitely stable at room temperature in dried state, and its light-emitting reaction is very simple. These unique characteristics of Vargula luciferase have prompted us to engineer chimeric protein, the other moiety chosen for conjugation being streptococcal protein G. A single domain of protein G which binds to IgG of a wide range of species was fused at the N-terminal region of Vargula luciferase. Unexpectedly, we found that the chimeric protein expressed in mammalian COS-1 cells had no IgG-binding ability, probably due to some sort of interaction between the two moieties or some conformational preferences of the IgG-binding domain of protein G when fused to Vargula luciferase. Here we report how we regained the IgG binding of protein G, by the intervention of three alpha-helices of protein A between protein G and luciferase. To our knowledge, the new chimeric protein provides the first reported model of this kind.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212866     DOI: 10.1006/abio.1997.2181

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

1.  Designing cell-targeted therapeutic proteins reveals the interplay between domain connectivity and cell binding.

Authors:  Avi Robinson-Mosher; Jan-Hung Chen; Jeffrey Way; Pamela A Silver
Journal:  Biophys J       Date:  2014-11-18       Impact factor: 4.033

Review 2.  Biomolecular engineering for nanobio/bionanotechnology.

Authors:  Teruyuki Nagamune
Journal:  Nano Converg       Date:  2017-04-24

3.  High-resolution mass spectrometry confirms the presence of a hydroxyproline (Hyp) post-translational modification in the GGGGP linker of an Fc-fusion protein.

Authors:  Chris Spahr; Kannan Gunasekaran; Kenneth W Walker; Stone D-H Shi
Journal:  MAbs       Date:  2017-05-16       Impact factor: 5.857

Review 4.  Fusion protein linkers: property, design and functionality.

Authors:  Xiaoying Chen; Jennica L Zaro; Wei-Chiang Shen
Journal:  Adv Drug Deliv Rev       Date:  2012-09-29       Impact factor: 15.470

5.  Insertion of inter-domain linkers improves expression and bioactivity of Zygote arrest (Zar) fusion proteins.

Authors:  Jonathan M Cook; Amanda Charlesworth
Journal:  Protein Eng Des Sel       Date:  2017-04-01       Impact factor: 1.650

6.  Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization.

Authors:  Yun Bai; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

Review 7.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

8.  Construction and evaluation of a novel bifunctional phenylalanine-formate dehydrogenase fusion protein for bienzyme system with cofactor regeneration.

Authors:  Wei Jiang; Bai-Shan Fang
Journal:  J Ind Microbiol Biotechnol       Date:  2016-01-27       Impact factor: 3.346

9.  Insertion of the designed helical linker led to increased expression of tf-based fusion proteins.

Authors:  Nurmamet Amet; Hsin-Fang Lee; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2008-11-11       Impact factor: 4.200

10.  Effects of Linker Flexibility and Conformational Changes of IP3 Receptor on Split Luciferase Complementation Assay.

Authors:  Maryam Moradi; Saman Hosseinkhani; Seyed Shahriar Arab; Anahita Khammari
Journal:  Iran J Biotechnol       Date:  2020-10-01       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.